ORPHAN DRUGS IN FRANCE: KEY MARKET ACCESS INCENTIVES

被引：0
|
作者：
Mennezein, L. [1 ]
Avot, D. [1 ]
Laigle, V [2 ]
机构：
[1] MSD France, Courbevoie, France
[2] MSD Vaccins, Lyon, France
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 09期
关键词：
D O I：
10.1016/j.jval.2017.08.943
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSY116
引用
收藏
页码：A565 / A565
页数：1
相关论文
共 50 条
  • [21] ORPHAN DRUGS FACE TOUGHER SCRUTINY IN SECURING FAVORABLE PRICING AND MARKET ACCESS
    Grosvenor, A.
    Saraf, S.
    Jones, K.
    VALUE IN HEALTH, 2011, 14 (03) : A22 - A22
  • [22] TIME TO MARKET ACCESS FOR INNOVATIVE DRUGS IN THE UK, FRANCE, AND BELGIUM
    Maervoet, J.
    Toumi, M.
    VALUE IN HEALTH, 2012, 15 (07) : A312 - A312
  • [23] MARKET ACCESS OF DRUGS IN FRANCE AND MEDICO-ECONOMIC ASSESSMENT
    Remuzat, C.
    Toumi, M.
    Aballea, S.
    VALUE IN HEALTH, 2012, 15 (07) : A312 - A312
  • [24] DETERMINANTS OF THE PRICES OF ORPHAN DRUGS IN FRANCE
    Lanecka, A. .
    Aballea, S.
    Reguei, I.
    Belgaied, W.
    Toumi, M.
    VALUE IN HEALTH, 2024, 27 (12)
  • [25] Ethical imperatives of timely access to orphan drugs: is possible to reconcile economic incentives and patients' health needs?
    Rodriguez-Monguio, R.
    Spargo, T.
    Seoane-Vazquez, E.
    ORPHANET JOURNAL OF RARE DISEASES, 2017, 12
  • [26] Ethical imperatives of timely access to orphan drugs: is possible to reconcile economic incentives and patients’ health needs?
    R. Rodriguez-Monguio
    T. Spargo
    E. Seoane-Vazquez
    Orphanet Journal of Rare Diseases, 12
  • [27] Mechanism of coordinated access to orphan drugs
    R DeRidder
    C Adriaens
    D Kleinermans
    M Mortier
    A Quanten
    F Arickx
    Orphanet Journal of Rare Diseases, 7 (Suppl 2)
  • [28] MECHANISM OF COORDINATED ACCESS TO ORPHAN DRUGS
    DeRidder, H.
    Arickx, F.
    Adriaens, C.
    Quanten, A.
    Mortier, M.
    Kleinermans, D.
    VALUE IN HEALTH, 2013, 16 (07) : A490 - A490
  • [29] PRICING AND MARKET ACCESS OF ORPHAN DRUGS IN ASIA: A COMPARATIVE STUDY ACROSS GROWTH MARKETS
    Sherwin, G.
    Akpinar, P.
    Saraf, S.
    Li, X.
    VALUE IN HEALTH, 2014, 17 (07) : A785 - A785
  • [30] TITLE: ACCESS TO ORPHAN AND ULTRA-ORPHAN DRUGS IN CHINA
    Gambari, J.
    Yang, M.
    Chowdhury, C. A.
    Duttagupta, S.
    VALUE IN HEALTH, 2016, 19 (07) : A826 - A826
12345